Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Ahua Biological Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of biochemical drugs and active pharmaceutical ingredients (APIs). The company is a leading global supplier of thrombolytic enzymes, most notably Urokinase, and a variety of reproductive hormones including Human Chorionic Gonadotrophin (HCG) and Menotrophins (HMG). Based in Liaocheng, Shandong, it operates large-scale GMP-certified facilities for both API extraction and finished dosage form production. The company's portfolio primarily serves the cardiovascular and reproductive health markets, providing essential treatments for conditions such as acute myocardial infarction and infertility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Ahua Biological Pharmaceutical.